Clinical Trial

Characterization of Neurocognitive Profiles in Neurodevelopmental Disorders and Epilepsy: a Transdiagnostic Approach

Study acronym: DIS-Neurodev
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Neurodevelopmental disorders (NDDs) are early-onset conditions affecting personal, social, and academic functioning, with high comorbidity rates and shared neurobiological traits. Traditional diagnostic categories struggle to explain symptom overlap, supporting a transdiagnostic approach that views NDDs as dimensions rather than distinct entities. This project aims to identify common neuropsychological and neurophysiological profiles in ADHD, autism, intellectual disability, and learning disorders using high-density EEG and cognitive tasks assessing cognitive control. By integrating neuropsychological assessments, EEG responses, and behavioral data, the study seeks to identify shared functional profiles rather than disorder-specific biomarkers. Additionally, it will analyze the relationship between NDDs and epilepsy to validate behavioral and neurophysiological markers. Conducted in collaboration with the University of Padua, the study employs advanced data analysis to enhance personalized interventions.
Trial Details
NCT Number NCT06877260
Lead Sponsor IRCCS Eugenio Medea
Collaborators: University of Padova
Conditions Neurodevelopmental Disorder (Diagnosis), Epilepsy
Enrollment 60 participants
Start Date 2024-11-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2027-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-14